In this cross-sectional analysis, researchers aimed to characterize the NIH trials affected by grant terminations under the Trump administration. More than 74,000 individuals were enrolled in active ...
(HealthDay News) — The oral small-molecule glucagon-like peptide 1 (GLP-1) receptor agonist orforglipron demonstrates superior weight loss as an adjunct to lifestyle modification versus placebo for ...
Having a longer travel time to their treatment facility improves survival in prostate cancer patients, according to a recent study.
PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.
Authors say widely available foods like tea, coffee, berries, olive oil, nuts, and whole grains may be a practical way to improve long-term cardiovascular disease risk.
No significant differences in mean cost of care or in 30-day readmission for home hospital versus brick-and-mortar hospital care.
(HealthDay News) — Most speakers attending U.S. Food and Drug Administration (FDA) Human Drug Advisory Committee meetings about new drugs or indications support approval, according to a research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback